225 related articles for article (PubMed ID: 32519340)
1. Versatile role of curcumin and its derivatives in lung cancer therapy.
Ashrafizadeh M; Najafi M; Makvandi P; Zarrabi A; Farkhondeh T; Samarghandian S
J Cell Physiol; 2020 Dec; 235(12):9241-9268. PubMed ID: 32519340
[TBL] [Abstract][Full Text] [Related]
2. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
[TBL] [Abstract][Full Text] [Related]
3. Curcumin: updated molecular mechanisms and intervention targets in human lung cancer.
Ye MX; Li Y; Yin H; Zhang J
Int J Mol Sci; 2012; 13(3):3959-3978. PubMed ID: 22489192
[TBL] [Abstract][Full Text] [Related]
4. Current Status and Perspectives Regarding the Therapeutic Potential of Targeting EGFR Pathway by Curcumin in Lung Cancer.
Shafiee M; Mohamadzade E; ShahidSales S; Khakpouri S; Maftouh M; Parizadeh SA; Hasanian SM; Avan A
Curr Pharm Des; 2017; 23(13):2002-2008. PubMed ID: 28117012
[TBL] [Abstract][Full Text] [Related]
5. Curcumin sensitizes human lung cancer cells to apoptosis and metastasis synergistically combined with carboplatin.
Kang JH; Kang HS; Kim IK; Lee HY; Ha JH; Yeo CD; Kang HH; Moon HS; Lee SH
Exp Biol Med (Maywood); 2015 Nov; 240(11):1416-25. PubMed ID: 25716014
[TBL] [Abstract][Full Text] [Related]
6. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
Liu H; Zhou BH; Qiu X; Wang HS; Zhang F; Fang R; Wang XF; Cai SH; Du J; Bu XZ
Free Radic Biol Med; 2012 Dec; 53(12):2204-17. PubMed ID: 23085518
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway.
Liu F; Gao S; Yang Y; Zhao X; Fan Y; Ma W; Yang D; Yang A; Yu Y
Oncol Rep; 2018 Mar; 39(3):1523-1531. PubMed ID: 29328421
[TBL] [Abstract][Full Text] [Related]
8. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells.
Reuter S; Eifes S; Dicato M; Aggarwal BB; Diederich M
Biochem Pharmacol; 2008 Dec; 76(11):1340-51. PubMed ID: 18755156
[TBL] [Abstract][Full Text] [Related]
9. Curcumin enhances the anti-cancer effects of Paris Saponin II in lung cancer cells.
Man S; Zhang L; Cui J; Yang L; Ma L; Gao W
Cell Prolif; 2018 Aug; 51(4):e12458. PubMed ID: 29608021
[TBL] [Abstract][Full Text] [Related]
10. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.
Kunnumakkara AB; Diagaradjane P; Anand P; Harikumar KB; Deorukhkar A; Gelovani J; Guha S; Krishnan S; Aggarwal BB
Int J Cancer; 2009 Nov; 125(9):2187-97. PubMed ID: 19623659
[TBL] [Abstract][Full Text] [Related]
11. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
[TBL] [Abstract][Full Text] [Related]
12. Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest.
Wang YT; Liu HS; Su CL
Int J Food Sci Nutr; 2014 May; 65(3):368-74. PubMed ID: 24438326
[TBL] [Abstract][Full Text] [Related]
13. Curcumin inhibits autocrine growth hormone-mediated invasion and metastasis by targeting NF-κB signaling and polyamine metabolism in breast cancer cells.
Coker-Gurkan A; Celik M; Ugur M; Arisan ED; Obakan-Yerlikaya P; Durdu ZB; Palavan-Unsal N
Amino Acids; 2018 Aug; 50(8):1045-1069. PubMed ID: 29770869
[TBL] [Abstract][Full Text] [Related]
14. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
[TBL] [Abstract][Full Text] [Related]
15. Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF-kappaB and upregulation of TRAIL receptors.
Kamat AM; Tharakan ST; Sung B; Aggarwal BB
Cancer Res; 2009 Dec; 69(23):8958-66. PubMed ID: 19903839
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of curcumin action: signal transduction.
Shehzad A; Lee YS
Biofactors; 2013; 39(1):27-36. PubMed ID: 23303697
[TBL] [Abstract][Full Text] [Related]
17. Curcumin and lung cancer--a review.
Mehta HJ; Patel V; Sadikot RT
Target Oncol; 2014 Dec; 9(4):295-310. PubMed ID: 24840628
[TBL] [Abstract][Full Text] [Related]
18. Curcumin and Lung Cancer: the Role of microRNAs.
Lelli D; Pedone C; Majeed M; Sahebkar A
Curr Pharm Des; 2017; 23(23):3440-3444. PubMed ID: 28067164
[TBL] [Abstract][Full Text] [Related]
19. Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma.
Sun ZJ; Chen G; Zhang W; Hu X; Liu Y; Zhou Q; Zhu LX; Zhao YF
Mol Pharmacol; 2011 Jan; 79(1):106-18. PubMed ID: 20959361
[TBL] [Abstract][Full Text] [Related]
20. Induction of microRNA-146a is involved in curcumin-mediated enhancement of temozolomide cytotoxicity against human glioblastoma.
Wu H; Liu Q; Cai T; Chen YD; Wang ZF
Mol Med Rep; 2015 Oct; 12(4):5461-6. PubMed ID: 26239619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
